Company:
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.
Shy of Covid 19 needles? No problem. Vaxart is in the process of creating a Covid 19 vaccine pill. Yes, it’s a pill. This summer they will start on their phase 2. The share price has been on the move this week after an analysis gave them a $18 target price. As of this writing the closing price is $8.74 a $1.56 increased today.
I sold my shares today when it reached $10. However, I will drop by in Monday for a few days swing. I think it has room to get up to $15 in a week or two if the market is not red.
Good luck trading.
